Price (delayed)
$0.1425
Market cap
$7.75M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.89
Enterprise value
-$15.39M
Galera Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing a pipeline of novel, proprietary therapeutics that have the potential to transform radiotherapy in cancer. Galera's lead
There are no recent dividends present for GRTX.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.